← Open Payments lookup

ALEXANDRA BEWLEY: Open Payments

NPI 1851772958 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$366 in 16 payments from 9 companies in 2025. Trend: 2023 $480 · 2024 $939 · 2025 $366

Food & beverage: $366
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$74
Takeda Pharmaceuticals U.S.A., Inc.3$68
Regeneron Healthcare Solutions, Inc.2$65
Grifols USA, LLC2$54
PFIZER INC.1$30
GENZYME CORPORATION1$24
BioCryst US Sales Co., LLC1$18
Phathom Pharmaceuticals, Inc.1$17
GlaxoSmithKline, LLC.1$16

Products named: DUPIXENT, AIRSUPRA, Xembify, HYQVIA, OCTAGAM IMMUNE GLOBULIN (HUMAN), TAKHZYRO, ORLADEYO, FASENRA.

Industry payments across TX — which companies pay providers there.